Mojtaba Falahati

Mojtaba Falahati is a Researcher at Erasmus University Medical Center working within the Pathology department. His research focuses on the intersection of nanotechnology and cancer therapy, with particular emphasis on developing novel nanosystems for targeted drug delivery and cancer immunotherapy.

Dr. Falahati's research interests span several key areas in nanomedicine and pharmacology:

• Nanoparticle-based cancer therapies
• Drug delivery systems for oncology applications
• Nanozymes and catalytic cancer therapy
• Protein-nanoparticle interactions in biological systems
• Pulmonary delivery of nanotherapeutics
• Targeted tumor treatment using advanced nanomaterials

His publication record demonstrates expertise in developing innovative approaches to cancer treatment through nanotechnology. Recent work has focused on lipid-based nanosystems for immune therapy, catalytic imaging-guided cancer therapy using nanozymes, and core-shell nanostructures for targeted drug delivery. His research bridges the gap between materials science, pharmacology, and clinical oncology, with the goal of improving therapeutic outcomes for cancer patients.

Dr. Falahati has established collaborations with researchers across multiple institutions, as evidenced by his co-authorship on numerous high-impact publications in top journals including Journal of Hematology and Oncology, Coordination Chemistry Reviews, and Advances in Colloid and Interface Science. His work has received significant attention in the scientific community, with several publications accumulating dozens of citations within a short timeframe.